Literature DB >> 2295789

Detection of IL-1 alpha and IL-1 beta in the supernatants of paraformaldehyde-treated human monocytes. Evidence against a membrane form of IL-1.

J Suttles1, L M Carruth, S B Mizel.   

Abstract

The concept of a membrane form of IL-1 arose from the observation that paraformaldehyde-treated macrophages display IL-1 bioactivity. Thus far, the biochemical characterization of a membrane form of the molecule has not been reported. In a recent publication we demonstrated that murine IL-1 alpha can be detected in the supernatants of paraformaldehyde-treated macrophages. These data indicate that the phenomenon of membrane IL-1 may result from leakage of IL-1 from inadequately fixed cells. In the current report we have extended our studies toward the examination of human IL-1 alpha and IL-1 beta. IL-1 activity can be detected in the supernatants of paraformaldehyde-treated human monocytes. Although anti-IL-1 alpha, but not anti-IL-1 beta, antibodies can efficiently block the IL-1 bioactivity, both IL-1 alpha and IL-1 beta can be found by immunoprecipitation in the supernatants of the fixed monocytes. IL-1 alpha is efficiently processed to the low m.w. form, whereas IL-1 beta remains predominantly as the inactive, precursor molecule. IL-1 is not found in the supernatants of monocyte membrane preparations, demonstrating that the leakage of IL-1 is from an intracellular, rather than membrane-bound source.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2295789

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  9 in total

Review 1.  Interleukin-1, immune activation pathways, and different mechanisms in osteoarthritis and rheumatoid arthritis.

Authors:  B Kirkham
Journal:  Ann Rheum Dis       Date:  1991-06       Impact factor: 19.103

2.  Inflammasome activation and IL-1β target IL-1α for secretion as opposed to surface expression.

Authors:  Antonia Fettelschoss; Magdalena Kistowska; Salomé LeibundGut-Landmann; Hans-Dietmar Beer; Pål Johansen; Gabriela Senti; Emmanuel Contassot; Martin F Bachmann; Lars E French; Annette Oxenius; Thomas M Kündig
Journal:  Proc Natl Acad Sci U S A       Date:  2011-10-17       Impact factor: 11.205

3.  Modulation of WC1, a lineage-specific cell surface molecule of gamma/delta T cells augments cellular proliferation.

Authors:  M D Hanby-Flarida; O J Trask; T J Yang; C L Baldwin
Journal:  Immunology       Date:  1996-05       Impact factor: 7.397

4.  The intratracheal administration of endotoxin and cytokines. I. Characterization of LPS-induced IL-1 and TNF mRNA expression and the LPS-, IL-1-, and TNF-induced inflammatory infiltrate.

Authors:  T R Ulich; L R Watson; S M Yin; K Z Guo; P Wang; H Thang; J del Castillo
Journal:  Am J Pathol       Date:  1991-06       Impact factor: 4.307

5.  Monocytes control gamma/delta T-cell responses by a secreted product.

Authors:  A J Okragly; M Hanby-Flarida; C L Baldwin
Journal:  Immunology       Date:  1995-12       Impact factor: 7.397

6.  Synthesis of IL-1 alpha and IL-1 beta by arterial cells in atherosclerosis.

Authors:  C F Moyer; D Sajuthi; H Tulli; J K Williams
Journal:  Am J Pathol       Date:  1991-04       Impact factor: 4.307

7.  Bovine gamma/delta T-cell proliferation is associated with self-derived molecules constitutively expressed in vivo on mononuclear phagocytes.

Authors:  A J Okragly; M Hanby-Flarida; D Mann; C L Baldwin
Journal:  Immunology       Date:  1996-01       Impact factor: 7.397

8.  Antibody-mediated enhancement of Legionella pneumophila-induced interleukin 1 activity.

Authors:  R H Widen; C A Newton; T W Klein; H Friedman
Journal:  Infect Immun       Date:  1993-10       Impact factor: 3.441

9.  Synthesis and release of interleukin 1 by reoxygenated human mononuclear phagocytes.

Authors:  S Koga; S Ogawa; K Kuwabara; J Brett; J A Leavy; J Ryan; Y Koga; J Plocinski; W Benjamin; D K Burns
Journal:  J Clin Invest       Date:  1992-09       Impact factor: 14.808

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.